Retrospective cost-effectiveness analyses for polio vaccination in the United States.
about
Multimorbidity in chronic disease: impact on health care resources and costsEnhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.Trends in the risk of U.S. polio outbreaks and poliovirus vaccine availability for response.Role of vaccination in economic growth.Vaccination: the cornerstone of an efficient healthcare system.Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay.Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.Expert review on poliovirus immunity and transmission.Categorization of methods used in cost-effectiveness analyses of vaccination programs based on outcomes from dynamic transmission models.Preeradication vaccine policy options for poliovirus infection and disease control.Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.Preventive Biomechanics: A Paradigm Shift With a Translational Approach to Injury Prevention.Questions regarding the safety and duration of immunity following live yellow fever vaccination.Long-term socio-economic consequences and health care costs of poliomyelitis: a historical cohort study involving 3606 polio patients.Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II.Individual-based modeling of potential poliovirus transmission in connected religious communities in North America with low uptake of vaccination.Framework for Optimal Global Vaccine Stockpile Design for Vaccine-Preventable Diseases: Application to Measles and Cholera Vaccines as Contrasting Examples.Investing in Health Innovation: A Cornerstone to Achieving Global Health Convergence.Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs.Modeling population immunity to support efforts to end the transmission of live polioviruses.Understanding public perceptions of benefits and risks of childhood vaccinations in the United States.Modeling poliovirus risks and the legacy of polio eradication.Unintended consequences and the paradox of control: Management of emerging pathogens with age-specific virulence.Developing new health technologies for neglected diseases: a pipeline portfolio review and cost model
P2860
Q26741437-506290BC-4AD0-42B9-8FCC-CB06EC2D303FQ28654939-F1D901EC-9A3E-4EEF-8EB0-165449C711B7Q34632088-02D3F800-7EC2-42FB-9094-5CF82C75FB82Q35603330-5441F28B-BAC6-4421-9066-09F7BB09B295Q36714658-B94BBC8E-2818-4166-B22D-CC2B3BCDEB23Q36714722-441CECE3-53E7-4AA8-A267-053E4792A615Q37116439-E8AF5D49-8496-4A2D-825C-592864514F44Q38006994-B02F6924-C72D-44B4-A2FF-04183FDF31B4Q38026922-CD1500C7-377B-47F0-8039-C48031CB61E9Q38027575-99353473-BC9D-471B-8847-1937DD16C8D2Q38086593-5616E1E2-4198-4365-AEEA-5468B24A2180Q38754363-35C65989-8440-4B01-B4D5-4F25D1F074B7Q39136667-52A5A8BB-C93C-4FC1-9F96-AD146A2B16D9Q39706701-899AE569-1A47-4FA5-9DFC-8F30B4D66864Q39847401-8366E8E4-BDE9-4EF4-BC4B-48E9F0A7831AQ40226719-42D79481-F535-4886-A0E7-0EC45FF26FCAQ41700694-47088AC8-9382-4EB3-814B-2E28B5EA9224Q42200855-346AF6CD-25E0-4978-95E6-B588FF50ECB9Q42623816-9E3608A0-90F8-4740-A0FE-25A34F867E14Q44271802-7CD41619-2EE5-4AF6-BC90-64A6F38954D6Q45326635-824732F2-B613-40B7-B3FA-44D507B07A7EQ48169492-3DB04D48-8C63-4CB2-8623-9EA85A198653Q53335042-64C51AF0-6193-492A-865E-152E9C558D7CQ54239461-C7591D26-C371-4B0B-B387-0E12C7F2D869Q58027781-550DF507-0092-488C-8CE7-ED0F3BD11701
P2860
Retrospective cost-effectiveness analyses for polio vaccination in the United States.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Retrospective cost-effectiveness analyses for polio vaccination in the United States.
@en
type
label
Retrospective cost-effectiveness analyses for polio vaccination in the United States.
@en
prefLabel
Retrospective cost-effectiveness analyses for polio vaccination in the United States.
@en
P2860
P1433
P1476
Retrospective cost-effectiveness analyses for polio vaccination in the United States
@en
P2860
P304
P356
10.1111/J.1539-6924.2006.00831.X
P577
2006-12-01T00:00:00Z